Source: Metabolomics. Unidade: FM
Subjects: VASOS CORONÁRIOS, LIPÍDEOS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Gesiane et al. 1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics. Metabolomics, v. 14, n. 4, 2018Tradução . . Disponível em: https://doi.org/10.1007/s11306-018-1337-9. Acesso em: 04 nov. 2024.APA
Tavares, G., Venturini, G., Padilha, K., Zatz, R., Pereira, A. C., Thadhian, R. I., et al. (2018). 1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics. Metabolomics, 14( 4). doi:10.1007/s11306-018-1337-9NLM
Tavares G, Venturini G, Padilha K, Zatz R, Pereira AC, Thadhian RI, Rhee EP, Titan SMO. 1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics [Internet]. Metabolomics. 2018 ; 14( 4):[citado 2024 nov. 04 ] Available from: https://doi.org/10.1007/s11306-018-1337-9Vancouver
Tavares G, Venturini G, Padilha K, Zatz R, Pereira AC, Thadhian RI, Rhee EP, Titan SMO. 1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics [Internet]. Metabolomics. 2018 ; 14( 4):[citado 2024 nov. 04 ] Available from: https://doi.org/10.1007/s11306-018-1337-9
